Joanie Bernier
Overview
Explore the profile of Joanie Bernier including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
141
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pankovitch S, Frohlich M, AlOthman B, Marciniuk J, Bernier J, Paul-Emile D, et al.
Chest
. 2024 Oct;
167(3):736-745.
PMID: 39384100
Background: COPD inhaler regimens should be appropriate for the patient's peak inspiratory flow (PIF) and should ideally consist of single or similar device(s). Research Questions: In a subspecialized COPD clinic:...
2.
Mizutani M, Berube J, Ahlgren H, Bernier J, Matouk E, Nguyen D, et al.
ERJ Open Res
. 2017 Jun;
3(2).
PMID: 28656134
Decreasing the inflammatory response that leads to tissue damage during cystic fibrosis (CF) lung disease has been a long-standing goal of CF therapy. While corticosteroids are widely used anti-inflammatory drugs,...
3.
Matouk E, Nguyen D, Benedetti A, Bernier J, Gruber J, Landry J, et al.
J Pulm Respir Med
. 2017 Jan;
6(5):1000375.
PMID: 28066689
Introduction: In stable adult cystic fibrosis (CF) patients, we assessed the role of baseline high sensitivity C-reactive protein (hs-CRP) on CF clinical variables and frequency of intravenous (IV) treated pulmonary...
4.
LaFayette S, Houle D, Beaudoin T, Wojewodka G, Radzioch D, Hoffman L, et al.
Sci Adv
. 2015 Oct;
1(6).
PMID: 26457326
Cystic fibrosis lung disease is characterized by chronic airway infections with the opportunistic pathogen and severe neutrophilic pulmonary inflammation. undergoes extensive genetic adaptation to the cystic fibrosis (CF) lung environment,...
5.
Ahlgren H, Benedetti A, Landry J, Bernier J, Matouk E, Radzioch D, et al.
BMC Pulm Med
. 2015 Jun;
15:67.
PMID: 26093634
Background: Staphylococcus aureus (SA) is the most prevalent organism infecting the respiratory tract of CF children, and remains the second most prevalent organism in CF adults. During early childhood, SA...
6.
Wojewodka G, De Sanctis J, Bernier J, Berube J, Ahlgren H, Gruber J, et al.
PLoS One
. 2014 Feb;
9(2):e88567.
PMID: 24533110
Introduction: Pulmonary exacerbations (PEs) cause significant morbidity and can severely impact disease progression in cystic fibrosis (CF) lung disease, especially in patients who suffer from recurrent PEs. The assessments able...
7.
Paquet F, Evans J, Begin O, Bernier J, Coutu P, Dowell N, et al.
Perspect Infirm
. 2011 Jul;
7(2):29-34.
PMID: 21744601
No abstract available.